SlideShare a Scribd company logo
1 of 7
Download to read offline
YOUR MINTVISORY Call us at +91-731-6642300
20 AUG 2018
DAILY EQUITY REPORT
Our Presence
Epic Research India
411 Milinda Manor (Suites 409- 417)
2 RNT Marg. Opp Central Mall
Indore (M.P.)
Hotline: +91 731 664 2300
Or give us a missed call at
026 5309 0639
HNI & NRI Sales Contact Australia
Mintara Road, Tarneit, Victoria. Post Code 3029
Phone.: +61 422 063855
HNI & NRI Sales Contact USA
2117 Arbor Vista Dr. Charlotte (NC)
Cell: +1 704 249 2315
Toll Free Number
1-800-200-9454
All queries should be directed to
Info@epicresearch.co
YOUR MINTVISORY Call us at +91-731-6642300
20 AUG 2018
DAILY MARKET WRAPUP
INDIAN INDICES
INDEX CMP Change % Chg
NIFTY 11470.75 +85.70 +0.75
SENSEX 37947.88 +284.32 +0.75
-0.16
Index Current % Change Open High Low Prev. Close
AUTO 10,878.70 0.44 10,891.75 10,936.50 10,865.00 10,830.95
FIN SERVICE 11,621.65 0.74 11,593.80 11,649.00 11,582.60 11,536.45
FMCG 32,340.05 1.92 31,799.20 32,383.20 31,785.95 31,731.25
IT 15,126.40 0.55 15,059.95 15,143.35 14,982.35 15,044.35
MEDIA 2,845.30 1 2,831.30 2,851.55 2,818.85 2,817.25
METAL 3,394.10 1.71 3,368.65 3,412.05 3,365.25 3,337.05
PHARMA 9,693.85 1.03 9,643.65 9,780.95 9,639.90 9,595.35
PSU BANK 3,222.05 3.02 3,154.35 3,230.10 3,146.45 3,127.45
REALTY 276.05 0.88 275 277 274.8 273.65
ENERGY 15,250.05 0.08 15,321.65 15,351.55 15,221.70 15,238.60
INFRA 3,092.15 0.5 3,088.35 3,098.30 3,084.40 3,076.65
MNC 14,774.10 1.37 14,642.95 14,789.20 14,631.25 14,575.10
PSE 3,614.90 -0.05 3,631.50 3,642.05 3,608.75 3,616.55
SERV SECTOR 15,477.50 0.57 15,451.30 15,494.05 15,434.65 15,389.75
GROWSECT 15 7,204.50 1.15 7,150.40 7,218.45 7,146.20 7,122.80
YOUR MINTVISORY Call us at +91-731-6642300
20 AUG 2018
EPIC RESEARCH– ANALYST SPEAKS
Nifty finished at all time highs but in previous week it dint cross all time high of 11495, according to spot market chart Nifty moving in rising
channel line pattern which followed in last week where Nifty traded near pattern support level here down side support is at 11400, if Nifty break
this level on closing basis then we can see two per cent fall, while on future market chart it is moving in rising wedge pattern and RSI also has
double top pattern where below 11274 it will divergence on RSI so be cautious at this points, here Nifty can be buy around 11400-11380 with
strict stop loss of 11200 for the target of 11550 11700 12000.
NIFTY
RESISTANCE 2 RESISTANCE 1 PIVOT SUPPORT 1 SUPPORT 2
11403.66 11387.33 11455.00 11471.66 11523.33
YOUR MINTVISORY Call us at +91-731-6642300
20 AUG 2018
EPIC RESEARCH– ANALYST SPEAKS
BANK NIFTY– In short term Bank Nifty future moving in open broadening pattern while on long term chart it is moving in rising wedge
chart pattern, according to short term is has support around 250 while in long term this is around 27250 so in next week it can be buy around
28100-28050 with stop loss of short term support level 27750 for the target of 28500 28700.
BANKNIFTY
RESISTANCE 2 RESISTANCE 1 PIVOT SUPPORT 1 SUPPORT 2
28331.67 28250.34 28127.67 28046.34 27923.67
YOUR MINTVISORY Call us at +91-731-6642300
20 AUG 2018
EPIC RESEARCH– ANALYST SPEAKS
GRANULES FUTURE - After a short consolidation stock outperformed well with above the average volumes on daily chart. The RSI also moving
up side on daily chart and it gave closing above the 200 SMA & EMA on daily chart. We recommend to buy from current level for the target of 115
with the stop loss of 108.
EPIC RESEARCH– ANALYST SPEAKS
GRANULES FUTURE
YOUR MINTVISORY Call us at +91-731-6642300
20 AUG 2018
EPIC RESEARCH– ANALYST SPEAKS
TORNTPHARM FUTURE - Stock was consolidating from past four trading sessions and it outperformed well with good volumes and closed near to
days high. It is also trading near to 52 week high. It should continue trend for next week. We recommend to buy from current level for the target
of 1780 with the stop loss of 1744.
TORNTPHARM FUTURE
YOUR MINTVISORY Call us at +91-731-6642300
20 AUG 2018
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any re-
sponsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.
Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up
on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility.
The information given herein should be treated as only factor, while making investment decision. The report does not provide individually
tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and
encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on
the information given in this report, which is in violation of rules and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all es-
timates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks
recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views ex-
pressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Any surfing and reading of
the information is the acceptance of this disclaimer. All Rights Reserved.
Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any
financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer
to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our
calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then
Serious Legal Actions can be taken.
DISCLAIMER

More Related Content

What's hot

Daily forex report 26 march 2014 by epic research
Daily forex report 26 march 2014 by epic researchDaily forex report 26 march 2014 by epic research
Daily forex report 26 march 2014 by epic research
Epic Research Limited
 

What's hot (20)

Daily equity report 10 august 2018 by epic research
Daily equity report 10 august 2018 by epic researchDaily equity report 10 august 2018 by epic research
Daily equity report 10 august 2018 by epic research
 
Daily equity report 05 october 2018 by epic research
Daily equity report 05 october 2018 by epic researchDaily equity report 05 october 2018 by epic research
Daily equity report 05 october 2018 by epic research
 
Daily equity report 17 august 2018 by epic research
Daily equity report 17 august 2018 by epic researchDaily equity report 17 august 2018 by epic research
Daily equity report 17 august 2018 by epic research
 
Daily equity-report-20-june-2018-by-epic-research
Daily equity-report-20-june-2018-by-epic-researchDaily equity-report-20-june-2018-by-epic-research
Daily equity-report-20-june-2018-by-epic-research
 
Weekly equity report 13 aug 2018 by epic research
Weekly equity report 13 aug 2018 by epic researchWeekly equity report 13 aug 2018 by epic research
Weekly equity report 13 aug 2018 by epic research
 
Epic research weekly equity report of 18 april 2016
Epic research weekly equity report of 18 april 2016Epic research weekly equity report of 18 april 2016
Epic research weekly equity report of 18 april 2016
 
Weekly equity report 24 sep 2018 by epic research
Weekly equity report 24 sep 2018 by epic researchWeekly equity report 24 sep 2018 by epic research
Weekly equity report 24 sep 2018 by epic research
 
Daily equity report 22 october 2018 by epic research
Daily equity report 22 october 2018 by epic researchDaily equity report 22 october 2018 by epic research
Daily equity report 22 october 2018 by epic research
 
Weekly equity report 30 jul 2018 by epic research
Weekly equity report 30 jul 2018 by epic researchWeekly equity report 30 jul 2018 by epic research
Weekly equity report 30 jul 2018 by epic research
 
Weekly equity report 03 sep 2018 by epic research
Weekly equity report 03 sep 2018 by epic researchWeekly equity report 03 sep 2018 by epic research
Weekly equity report 03 sep 2018 by epic research
 
Daily equity report 14 nov 2018 by epic research
Daily equity report 14 nov 2018 by epic researchDaily equity report 14 nov 2018 by epic research
Daily equity report 14 nov 2018 by epic research
 
Daily equity-report-11-may-2018-by-epic-research
Daily equity-report-11-may-2018-by-epic-researchDaily equity-report-11-may-2018-by-epic-research
Daily equity-report-11-may-2018-by-epic-research
 
Daily equity report 02 august 2018 by epic research
Daily equity report 02 august 2018 by epic researchDaily equity report 02 august 2018 by epic research
Daily equity report 02 august 2018 by epic research
 
Daily-equity-report-21-june-2018-by-epic-research
Daily-equity-report-21-june-2018-by-epic-researchDaily-equity-report-21-june-2018-by-epic-research
Daily-equity-report-21-june-2018-by-epic-research
 
Weekly equity report by epic research of 27 june 2016
Weekly  equity report by epic research  of 27 june 2016Weekly  equity report by epic research  of 27 june 2016
Weekly equity report by epic research of 27 june 2016
 
Daily equity report 24 september 2018 by epic research
Daily equity report 24 september 2018 by epic researchDaily equity report 24 september 2018 by epic research
Daily equity report 24 september 2018 by epic research
 
Daily forex report 26 march 2014 by epic research
Daily forex report 26 march 2014 by epic researchDaily forex report 26 march 2014 by epic research
Daily forex report 26 march 2014 by epic research
 
Daily equity report 03 august 2018 by epic research
Daily equity report 03 august 2018 by epic researchDaily equity report 03 august 2018 by epic research
Daily equity report 03 august 2018 by epic research
 
Daily equity report 23 july 2018 by epic research
Daily equity report 23 july 2018 by epic researchDaily equity report 23 july 2018 by epic research
Daily equity report 23 july 2018 by epic research
 
Daily equity report 30 august 2018 by epic research
Daily equity report 30 august 2018 by epic researchDaily equity report 30 august 2018 by epic research
Daily equity report 30 august 2018 by epic research
 

Similar to Daily equity report 20 august 2018 by epic research

Similar to Daily equity report 20 august 2018 by epic research (20)

Daily equity report 24 august 2018 by epic research
Daily equity report 24 august 2018 by epic researchDaily equity report 24 august 2018 by epic research
Daily equity report 24 august 2018 by epic research
 
Daily equity report 06 august 2018 by epic research
Daily equity report 06 august 2018 by epic researchDaily equity report 06 august 2018 by epic research
Daily equity report 06 august 2018 by epic research
 
Daily equity report 15 nov 2018 by epic research
Daily equity report 15 nov 2018 by epic research Daily equity report 15 nov 2018 by epic research
Daily equity report 15 nov 2018 by epic research
 
Daily equity report 14 august 2018 by epic research
Daily equity report 14 august 2018 by epic researchDaily equity report 14 august 2018 by epic research
Daily equity report 14 august 2018 by epic research
 
Daily equity report 17 july 2018
Daily equity report 17 july 2018Daily equity report 17 july 2018
Daily equity report 17 july 2018
 
Daily equity report 21 august 2018 by epic research
Daily equity report 21 august 2018 by epic researchDaily equity report 21 august 2018 by epic research
Daily equity report 21 august 2018 by epic research
 
Daily equity report 18 june 2018
Daily equity report 18 june 2018Daily equity report 18 june 2018
Daily equity report 18 june 2018
 
Daily equity report 29 august 2018 by epic research
Daily equity report 29 august 2018 by epic researchDaily equity report 29 august 2018 by epic research
Daily equity report 29 august 2018 by epic research
 
Daily equity report 20 july 2018
Daily equity report 20 july 2018Daily equity report 20 july 2018
Daily equity report 20 july 2018
 
Daily equity report 20 nov 2018 by epic research
Daily  equity report 20 nov 2018 by epic researchDaily  equity report 20 nov 2018 by epic research
Daily equity report 20 nov 2018 by epic research
 
Daily equity-report-04-june-2018-by-epic-research
Daily equity-report-04-june-2018-by-epic-researchDaily equity-report-04-june-2018-by-epic-research
Daily equity-report-04-june-2018-by-epic-research
 
Daily equity report 09 nov 2018 epic research
Daily equity report 09 nov 2018 epic researchDaily equity report 09 nov 2018 epic research
Daily equity report 09 nov 2018 epic research
 
Daily equity report 24 dec 2018 by epic research
Daily equity report 24 dec 2018 by epic researchDaily equity report 24 dec 2018 by epic research
Daily equity report 24 dec 2018 by epic research
 
Daily equity report 09 october 2018 by epic research
Daily equity report 09 october 2018 by epic researchDaily equity report 09 october 2018 by epic research
Daily equity report 09 october 2018 by epic research
 
Daily equity report 31 october 2018 by epic research
Daily equity report 31 october 2018 by epic researchDaily equity report 31 october 2018 by epic research
Daily equity report 31 october 2018 by epic research
 
Daily equity report 24 july 2018 by epic research
Daily equity report 24 july 2018 by epic researchDaily equity report 24 july 2018 by epic research
Daily equity report 24 july 2018 by epic research
 
Daily equity report 30 nov 2018 by epic research
Daily  equity report 30 nov 2018 by epic researchDaily  equity report 30 nov 2018 by epic research
Daily equity report 30 nov 2018 by epic research
 
Daily equity report by epic research of 18 july 2017
Daily equity report by epic research of 18 july 2017Daily equity report by epic research of 18 july 2017
Daily equity report by epic research of 18 july 2017
 
Daily equity report 23 october 2018 by epic research
Daily equity report 23 october 2018 by epic researchDaily equity report 23 october 2018 by epic research
Daily equity report 23 october 2018 by epic research
 
Daily equity report 25 october 2018 by epic research
Daily equity report 25 october 2018 by epic researchDaily equity report 25 october 2018 by epic research
Daily equity report 25 october 2018 by epic research
 

Recently uploaded

Obat Aborsi Depok 0851\7696\3835 Jual Obat Cytotec Di Depok
Obat Aborsi Depok 0851\7696\3835 Jual Obat Cytotec Di DepokObat Aborsi Depok 0851\7696\3835 Jual Obat Cytotec Di Depok
Obat Aborsi Depok 0851\7696\3835 Jual Obat Cytotec Di Depok
Obat Aborsi Jakarta Wa 085176963835 Apotek Jual Obat Cytotec Di Jakarta
 
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in PakistanChallenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
vineshkumarsajnani12
 
Jual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg Pfizer
Jual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg PfizerJual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg Pfizer
Jual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg Pfizer
Pusat Herbal
 
Contact +971581248768 for 100% original and safe abortion pills available for...
Contact +971581248768 for 100% original and safe abortion pills available for...Contact +971581248768 for 100% original and safe abortion pills available for...
Contact +971581248768 for 100% original and safe abortion pills available for...
DUBAI (+971)581248768 BUY ABORTION PILLS IN ABU dhabi...Qatar
 
Shots fired Budget Presentation.pdf12312
Shots fired Budget Presentation.pdf12312Shots fired Budget Presentation.pdf12312
Shots fired Budget Presentation.pdf12312
LR1709MUSIC
 
Obat Aborsi Pasuruan 0851\7696\3835 Jual Obat Cytotec Di Pasuruan
Obat Aborsi Pasuruan 0851\7696\3835 Jual Obat Cytotec Di PasuruanObat Aborsi Pasuruan 0851\7696\3835 Jual Obat Cytotec Di Pasuruan
Obat Aborsi Pasuruan 0851\7696\3835 Jual Obat Cytotec Di Pasuruan
Obat Aborsi Jakarta Wa 085176963835 Apotek Jual Obat Cytotec Di Jakarta
 
obat aborsi bandung wa 081336238223 jual obat aborsi cytotec asli di bandung9...
obat aborsi bandung wa 081336238223 jual obat aborsi cytotec asli di bandung9...obat aborsi bandung wa 081336238223 jual obat aborsi cytotec asli di bandung9...
obat aborsi bandung wa 081336238223 jual obat aborsi cytotec asli di bandung9...
yulianti213969
 
Obat Aborsi Malang 0851\7696\3835 Jual Obat Cytotec Di Malang
Obat Aborsi Malang 0851\7696\3835 Jual Obat Cytotec Di MalangObat Aborsi Malang 0851\7696\3835 Jual Obat Cytotec Di Malang
Obat Aborsi Malang 0851\7696\3835 Jual Obat Cytotec Di Malang
Obat Aborsi Jakarta Wa 085176963835 Apotek Jual Obat Cytotec Di Jakarta
 
Obat Aborsi Bandung 0851\7696\3835 Jual Obat Cytotec Di Bandung
Obat Aborsi Bandung 0851\7696\3835 Jual Obat Cytotec Di BandungObat Aborsi Bandung 0851\7696\3835 Jual Obat Cytotec Di Bandung
Obat Aborsi Bandung 0851\7696\3835 Jual Obat Cytotec Di Bandung
Obat Aborsi Jakarta Wa 085176963835 Apotek Jual Obat Cytotec Di Jakarta
 

Recently uploaded (20)

Thompson_Taylor_MBBS_PB1_2024-03 (1)- Project & Portfolio 2.pptx
Thompson_Taylor_MBBS_PB1_2024-03 (1)- Project & Portfolio 2.pptxThompson_Taylor_MBBS_PB1_2024-03 (1)- Project & Portfolio 2.pptx
Thompson_Taylor_MBBS_PB1_2024-03 (1)- Project & Portfolio 2.pptx
 
Progress Report - UKG Analyst Summit 2024 - A lot to do - Good Progress1-1.pdf
Progress Report - UKG Analyst Summit 2024 - A lot to do - Good Progress1-1.pdfProgress Report - UKG Analyst Summit 2024 - A lot to do - Good Progress1-1.pdf
Progress Report - UKG Analyst Summit 2024 - A lot to do - Good Progress1-1.pdf
 
Obat Aborsi Depok 0851\7696\3835 Jual Obat Cytotec Di Depok
Obat Aborsi Depok 0851\7696\3835 Jual Obat Cytotec Di DepokObat Aborsi Depok 0851\7696\3835 Jual Obat Cytotec Di Depok
Obat Aborsi Depok 0851\7696\3835 Jual Obat Cytotec Di Depok
 
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in PakistanChallenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
 
WheelTug Short Pitch Deck 2024 | Byond Insights
WheelTug Short Pitch Deck 2024 | Byond InsightsWheelTug Short Pitch Deck 2024 | Byond Insights
WheelTug Short Pitch Deck 2024 | Byond Insights
 
Jual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg Pfizer
Jual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg PfizerJual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg Pfizer
Jual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg Pfizer
 
Contact +971581248768 for 100% original and safe abortion pills available for...
Contact +971581248768 for 100% original and safe abortion pills available for...Contact +971581248768 for 100% original and safe abortion pills available for...
Contact +971581248768 for 100% original and safe abortion pills available for...
 
Shots fired Budget Presentation.pdf12312
Shots fired Budget Presentation.pdf12312Shots fired Budget Presentation.pdf12312
Shots fired Budget Presentation.pdf12312
 
10 Easiest Ways To Buy Verified TransferWise Accounts
10 Easiest Ways To Buy Verified TransferWise Accounts10 Easiest Ways To Buy Verified TransferWise Accounts
10 Easiest Ways To Buy Verified TransferWise Accounts
 
Elevate Your Online Presence with SEO Services
Elevate Your Online Presence with SEO ServicesElevate Your Online Presence with SEO Services
Elevate Your Online Presence with SEO Services
 
wagamamaLab presentation @MIT 20240509 IRODORI
wagamamaLab presentation @MIT 20240509 IRODORIwagamamaLab presentation @MIT 20240509 IRODORI
wagamamaLab presentation @MIT 20240509 IRODORI
 
Sex service available my WhatsApp number 7374088497
Sex service available my WhatsApp number 7374088497Sex service available my WhatsApp number 7374088497
Sex service available my WhatsApp number 7374088497
 
Obat Aborsi Pasuruan 0851\7696\3835 Jual Obat Cytotec Di Pasuruan
Obat Aborsi Pasuruan 0851\7696\3835 Jual Obat Cytotec Di PasuruanObat Aborsi Pasuruan 0851\7696\3835 Jual Obat Cytotec Di Pasuruan
Obat Aborsi Pasuruan 0851\7696\3835 Jual Obat Cytotec Di Pasuruan
 
How Bookkeeping helps you in Cost Saving, Tax Saving and Smooth Business Runn...
How Bookkeeping helps you in Cost Saving, Tax Saving and Smooth Business Runn...How Bookkeeping helps you in Cost Saving, Tax Saving and Smooth Business Runn...
How Bookkeeping helps you in Cost Saving, Tax Saving and Smooth Business Runn...
 
Pitch Deck Teardown: Goodcarbon's $5.5m Seed deck
Pitch Deck Teardown: Goodcarbon's $5.5m Seed deckPitch Deck Teardown: Goodcarbon's $5.5m Seed deck
Pitch Deck Teardown: Goodcarbon's $5.5m Seed deck
 
Moradia Isolada com Logradouro; Detached house with patio in Penacova
Moradia Isolada com Logradouro; Detached house with patio in PenacovaMoradia Isolada com Logradouro; Detached house with patio in Penacova
Moradia Isolada com Logradouro; Detached house with patio in Penacova
 
obat aborsi bandung wa 081336238223 jual obat aborsi cytotec asli di bandung9...
obat aborsi bandung wa 081336238223 jual obat aborsi cytotec asli di bandung9...obat aborsi bandung wa 081336238223 jual obat aborsi cytotec asli di bandung9...
obat aborsi bandung wa 081336238223 jual obat aborsi cytotec asli di bandung9...
 
Obat Aborsi Malang 0851\7696\3835 Jual Obat Cytotec Di Malang
Obat Aborsi Malang 0851\7696\3835 Jual Obat Cytotec Di MalangObat Aborsi Malang 0851\7696\3835 Jual Obat Cytotec Di Malang
Obat Aborsi Malang 0851\7696\3835 Jual Obat Cytotec Di Malang
 
Obat Aborsi Bandung 0851\7696\3835 Jual Obat Cytotec Di Bandung
Obat Aborsi Bandung 0851\7696\3835 Jual Obat Cytotec Di BandungObat Aborsi Bandung 0851\7696\3835 Jual Obat Cytotec Di Bandung
Obat Aborsi Bandung 0851\7696\3835 Jual Obat Cytotec Di Bandung
 
Most Visionary Leaders in Cloud Revolution, Shaping Tech’s Next Era - 2024 (2...
Most Visionary Leaders in Cloud Revolution, Shaping Tech’s Next Era - 2024 (2...Most Visionary Leaders in Cloud Revolution, Shaping Tech’s Next Era - 2024 (2...
Most Visionary Leaders in Cloud Revolution, Shaping Tech’s Next Era - 2024 (2...
 

Daily equity report 20 august 2018 by epic research

  • 1. YOUR MINTVISORY Call us at +91-731-6642300 20 AUG 2018 DAILY EQUITY REPORT Our Presence Epic Research India 411 Milinda Manor (Suites 409- 417) 2 RNT Marg. Opp Central Mall Indore (M.P.) Hotline: +91 731 664 2300 Or give us a missed call at 026 5309 0639 HNI & NRI Sales Contact Australia Mintara Road, Tarneit, Victoria. Post Code 3029 Phone.: +61 422 063855 HNI & NRI Sales Contact USA 2117 Arbor Vista Dr. Charlotte (NC) Cell: +1 704 249 2315 Toll Free Number 1-800-200-9454 All queries should be directed to Info@epicresearch.co
  • 2. YOUR MINTVISORY Call us at +91-731-6642300 20 AUG 2018 DAILY MARKET WRAPUP INDIAN INDICES INDEX CMP Change % Chg NIFTY 11470.75 +85.70 +0.75 SENSEX 37947.88 +284.32 +0.75 -0.16 Index Current % Change Open High Low Prev. Close AUTO 10,878.70 0.44 10,891.75 10,936.50 10,865.00 10,830.95 FIN SERVICE 11,621.65 0.74 11,593.80 11,649.00 11,582.60 11,536.45 FMCG 32,340.05 1.92 31,799.20 32,383.20 31,785.95 31,731.25 IT 15,126.40 0.55 15,059.95 15,143.35 14,982.35 15,044.35 MEDIA 2,845.30 1 2,831.30 2,851.55 2,818.85 2,817.25 METAL 3,394.10 1.71 3,368.65 3,412.05 3,365.25 3,337.05 PHARMA 9,693.85 1.03 9,643.65 9,780.95 9,639.90 9,595.35 PSU BANK 3,222.05 3.02 3,154.35 3,230.10 3,146.45 3,127.45 REALTY 276.05 0.88 275 277 274.8 273.65 ENERGY 15,250.05 0.08 15,321.65 15,351.55 15,221.70 15,238.60 INFRA 3,092.15 0.5 3,088.35 3,098.30 3,084.40 3,076.65 MNC 14,774.10 1.37 14,642.95 14,789.20 14,631.25 14,575.10 PSE 3,614.90 -0.05 3,631.50 3,642.05 3,608.75 3,616.55 SERV SECTOR 15,477.50 0.57 15,451.30 15,494.05 15,434.65 15,389.75 GROWSECT 15 7,204.50 1.15 7,150.40 7,218.45 7,146.20 7,122.80
  • 3. YOUR MINTVISORY Call us at +91-731-6642300 20 AUG 2018 EPIC RESEARCH– ANALYST SPEAKS Nifty finished at all time highs but in previous week it dint cross all time high of 11495, according to spot market chart Nifty moving in rising channel line pattern which followed in last week where Nifty traded near pattern support level here down side support is at 11400, if Nifty break this level on closing basis then we can see two per cent fall, while on future market chart it is moving in rising wedge pattern and RSI also has double top pattern where below 11274 it will divergence on RSI so be cautious at this points, here Nifty can be buy around 11400-11380 with strict stop loss of 11200 for the target of 11550 11700 12000. NIFTY RESISTANCE 2 RESISTANCE 1 PIVOT SUPPORT 1 SUPPORT 2 11403.66 11387.33 11455.00 11471.66 11523.33
  • 4. YOUR MINTVISORY Call us at +91-731-6642300 20 AUG 2018 EPIC RESEARCH– ANALYST SPEAKS BANK NIFTY– In short term Bank Nifty future moving in open broadening pattern while on long term chart it is moving in rising wedge chart pattern, according to short term is has support around 250 while in long term this is around 27250 so in next week it can be buy around 28100-28050 with stop loss of short term support level 27750 for the target of 28500 28700. BANKNIFTY RESISTANCE 2 RESISTANCE 1 PIVOT SUPPORT 1 SUPPORT 2 28331.67 28250.34 28127.67 28046.34 27923.67
  • 5. YOUR MINTVISORY Call us at +91-731-6642300 20 AUG 2018 EPIC RESEARCH– ANALYST SPEAKS GRANULES FUTURE - After a short consolidation stock outperformed well with above the average volumes on daily chart. The RSI also moving up side on daily chart and it gave closing above the 200 SMA & EMA on daily chart. We recommend to buy from current level for the target of 115 with the stop loss of 108. EPIC RESEARCH– ANALYST SPEAKS GRANULES FUTURE
  • 6. YOUR MINTVISORY Call us at +91-731-6642300 20 AUG 2018 EPIC RESEARCH– ANALYST SPEAKS TORNTPHARM FUTURE - Stock was consolidating from past four trading sessions and it outperformed well with good volumes and closed near to days high. It is also trading near to 52 week high. It should continue trend for next week. We recommend to buy from current level for the target of 1780 with the stop loss of 1744. TORNTPHARM FUTURE
  • 7. YOUR MINTVISORY Call us at +91-731-6642300 20 AUG 2018 The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any re- sponsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE. The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all es- timates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views ex- pressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Any surfing and reading of the information is the acceptance of this disclaimer. All Rights Reserved. Investment in equity & bullion market has its own risks. We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken. DISCLAIMER